Literature DB >> 24192290

The imbalance of Th17 and regulatory T cells in pemphigus patients.

Ren-Chao Xu1, Hai-Qin Zhu1, Wei-Ping Li1, Xiao-Qing Zhao1, Hui-Jie Yuan1, Jie Zheng1, Meng Pan1.   

Abstract

UNLABELLED: Pemphigus is a complex dermatologic autoimmune bullous disease whose pathogenic mechanism is not fully understood. Anti-desmoglein-1 (Dsg1) and anti- Dsg3 autoantibodies play an important role in the pathogenesis of pemphigus.
OBJECTIVES: To investigate the role of T-helper17 (Th17) and regulatory T (Treg) cells in the pathogenesis of pemphigus in fifty-one patients and twenty-six healthy individuals (control group).
METHODS: Levels of CD3(+)CD8(-) IL-17 expressing Th cells and CD4(+)CD25(hi)Foxp3(+) Treg cells were determined by FACS in both groups, along with anti-Dsg1 and Dsg3 antibody titers. An analysis of the correlation between Th17 and Treg cells was performed.
RESULTS: Th17 cell numbers were significantly higher in pemphigus patients than in normal controls (P = 0.014), especially in the acute onset and chronic active stages (P = 0.004 and 0.022). Conversely, Treg cells in pemphigus patients were significantly fewer than in the control group (P<0.001). The same trend was observed between the acute onset and the remittent stage patients (P = 0.006). We found a negative correlation between Th17 and Treg cell populations (r = -0.532, P<0.001). Anti-Dsg1 and Dsg3 antibody titers were higher in patients in the active stage than in the remittent stage, with an increased IgG4/IgG1 subclass ratio. There was no statistically significant correlation between Th17/Treg ratios and anti-Dsg1 or Dsg3 antibody titers.
CONCLUSION: These findings show an imbalance of Th17 and Treg cell populations in pemphigus patients, which might result in the activation and proliferation of effector T cells, further up-regulating B cell activity and antibody production.

Entities:  

Keywords:  Anti-Dsg1 or Dsg3 Antibody; Pemphigus; Regulatory T cells; Th17 cells

Mesh:

Substances:

Year:  2013        PMID: 24192290     DOI: 10.1684/ejd.2013.2177

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  15 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Th17 cells and Tregs: unlikely allies.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2014-02-21       Impact factor: 4.962

Review 3.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 4.  The emerging role of T cells in pemphigus vulgaris: a systematic review.

Authors:  Farnaz Araghi; Sahar Dadkhahfar; Reza M Robati; Mohammadreza Tabary; Mohammad Shahidi-Dadras
Journal:  Clin Exp Med       Date:  2022-08-04       Impact factor: 5.057

5.  Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.

Authors:  Pegah Shahbazian; Maryam Izad; Maryam Daneshpazhooh; Hossein Mortazavi; Zahra Salehi; Shirin Behruzifar; Soheil Tavakolpour; Arghavan Azizpour
Journal:  Dermatol Pract Concept       Date:  2021-04-12

6.  Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris.

Authors:  Neha Joshi; Ranjana W Minz; Shashi Anand; Nisha V Parmar; Amrinder J Kanwar
Journal:  BMC Res Notes       Date:  2014-08-15

7.  Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.

Authors:  Tina Hennerici; Robert Pollmann; Thomas Schmidt; Maria Seipelt; Björn Tackenberg; Christian Möbs; Kamran Ghoreschi; Michael Hertl; Rüdiger Eming
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

8.  Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus.

Authors:  Menglei Wang; Liuping Liang; Li Li; Kai Han; Qian Li; Yusheng Peng; Xuebiao Peng; Kang Zeng
Journal:  Mol Med Rep       Date:  2017-04-03       Impact factor: 2.952

Review 9.  The Genetics of Pemphigus Vulgaris.

Authors:  Dan Vodo; Ofer Sarig; Eli Sprecher
Journal:  Front Med (Lausanne)       Date:  2018-08-14

10.  Involvement of the IL23/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus.

Authors:  M Ben Jmaa; O Abida; R Fakhfakh; E Bahloul; Kh Sellami; L Gaddour; N Elloumi; M Ben Ayed; A Masmoudi; M Dhouib; M Abdelmoula; N Mahfoudh; H Makni; H Turki; H Masmoudi
Journal:  Mediators Inflamm       Date:  2018-07-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.